contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


hamlet-biopharma-ab-publ-invitation-to-digital-meeting-focusing-on-novel-strategies-for-treating-bacterial-infections-without-antibiotics

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Hamlet BioPharma är verksamt inom läkemedelsbranschen. Bolaget bedriver läkemedelsutveckling baserat på ett tumördödande protein-lipidkomplex, bildat av två naturliga och ofarliga molekyler som finns i bröstmjölk. Utvecklingen syftar till att ta fram preparat som primärt ska användas för behandling och prevention av cancersjukdomar. Hamlet BioPharma grundades år 2015 och har huvudkontor i Lund.

Hamlet BioPharma

Welcome to Hamlet BioPharma's monthly digital meeting on January 21 at 12:00, held the same day as the Davos Summit discusses `'The Fragile Future of Antibiotics. `'As stated in the Davos Summit...

<div class="abstract">Welcome to Hamlet BioPharma's monthly digital meeting on January 21 at 12:00, held the same day as the Davos Summit discusses `'The Fragile Future of Antibiotics. `'</div><img width="160" src="https://mb.cision.com/Public/13052/4293650/902cdf1f926382e3_800x800ar.png" height="113" alt="">As stated in the Davos Summit Program: "Antimicrobial resistance (AMR) is already undermining modern medicine. As superbugs evolve faster than new treatments can be developed, once-manageable infections are becoming harder to cure, threatening everything from surgery to cancer care. How can we ensure global access to life-saving antibiotics while preserving their effectiveness for generations to come?"<a href="https://www.weforum.org/meetings/world-economic-forum-annual-meeting-2026/programme">https://www.weforum.org/meetings/world-economic-forum-annual-meeting-2026/programme</a>Our discussions will focus on the groundbreaking ongoing development in Hamlet BioPharma's novel strategies for treating bacterial infections without antibiotics. Results from a successful clinical study were recently accepted for publication in Nature Microbiology, a leading international journal in the field of infection. Link to the meeting: https://us06web.zoom.us/j/88631809029?pwd=Uy1FVnDW5B7mc3D5cA2NCA5Kquh1jm.1For more information please contact:Catharina Svanborg, Chair of the Board, Hamlet BioPharma, +46-709 42 65 49<a href="mailto:catharina.svanborg@hamletpharma.com">catharina.svanborg@hamletpharma.com</a>&nbsp;Ines Ambite, Senior Scientist, Lund University, +46-762 08 89 58<a href="mailto:ines.ambite@med.lu.sem">ines.ambite@med.lu.se</a>&nbsp;<a href="http://www.hamletbiopharma.com">www.hamletbiopharma.com</a><div></div>

Hamlet BioPharma AB (publ): Invitation to digital meeting focusing on novel strategies for treating bacterial infections without antibiotics

Saab

Bittium

W5 Solutions

Scandinavian Astor Group

MilDef Group

INVISIO

Argo Defence Group

Europeisk försvarssektor: Långsiktig återupprustning driver fundamentala värden, men aggressiva värderingar tvingar fram selektivitet

Börs och träning

Vikten av att tänka själv

Finansiella nyckeltal: EV/EBIT, EV/EBITA, EV/EBITDA och EV/Sales

Guldlock i euroområdet?